NCT06799806 The Impact of the Therapeutic Virtual Reality Headset on Patient Anxiety in the Waiting Room Before Flexible Bronchoscopy in Vigil
| NCT ID | NCT06799806 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier le Mans |
| Condition | Bronchial Fibroscopy |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-02-27 |
| Primary Completion | 2026-02-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-02-27 with a primary completion date of 2026-02-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bronchial fibroscopy is a frequently used procedure in the management of pneumology patients, and can be a source of anxiety, particularly while waiting for the examination. Investigator's professional experience has shown us that many patients are anxious in the waiting room before a flexible bronchoscopy in vigile. A great deal of research has been carried out into the use of virtual reality to reduce anxiety and pain during care but shortly before bronchoscopy. The innovative aspect is to target the patient's waiting time for the examination. Waiting is a highly anxiety-provoking time, and nurses play a vital role in supporting patients.
Eligibility Criteria
Inclusion Criteria: * Adult patients with no age or gender restrictions, seen on an outpatient basis at Le Mans Hospital. * In whom bronchial fibroscopy is indicated. * Person affiliated with or benefiting from a social security . * Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination required by the research). * Patient able and willing to answer questionnaires Exclusion Criteria: * Patient refusing to participate in research * Patient who has already undergone bronchoscopy in vigil * Patient premedicated for bronchial fibroscopy (anxiolytic, etc.) * Patients with a history of epilepsy or psychiatric pathology * Patient with vertigo * Patient uncooperative, demented or unable to tolerate headgear. * patient under guardianship or curatorship * Patients suffering from blindness or deafness * Patient with known significant intolerance to screens and/or virtual reality devices * Pregnant, nursing or parturient women * Unscheduled patients: emergencies, etc. * Hospitalized patients
Contact & Investigator
Christine PETIT
PRINCIPAL INVESTIGATOR
Centre Hospitalier le Mans
Frequently Asked Questions
Who can join the NCT06799806 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bronchial Fibroscopy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06799806 currently recruiting?
Yes, NCT06799806 is actively recruiting participants. Contact the research team at cjadeau@ch-lemans.fr for enrollment information.
Where is the NCT06799806 trial being conducted?
This trial is being conducted at Le Mans, France.
Who is sponsoring the NCT06799806 clinical trial?
NCT06799806 is sponsored by Centre Hospitalier le Mans. The principal investigator is Christine PETIT at Centre Hospitalier le Mans. The trial plans to enroll 80 participants.